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Abstract 
Thyroid hormone (T3) has been suggested to participate in the regulation of herpesvirus replication during reactiva-
tion. Clinical observations and in vivo experiments suggest that T3 are involved in the suppression of herpes virus 
replication. In vitro, differentiated LNCaP cells, a human neuron-like cells, further resisted HSV-1 replication upon addi-
tion of T3. Previous studies indicate that T3 controlled the expression of several key viral genes via its nuclear receptors 
in differentiated LNCaP cells. Additional observation showed that differentiated LNCaP cells have active PI3K signaling 
and inhibitor LY294002 can reverse T3-mediated repression of viral replication. Active PI3K signaling has been linked to 
HSV-1 latency in neurons. The hypothesis is that, in addition to repressing viral gene transcription at the nuclear level, 
T3 may influence PI3K signaling to control HSV-1 replication in human neuron-like cells. We review the genomic and 
non-genomic regulatory roles of T3 by examining the phosphoinositide 3-kinase (PI3K) pathway gene expression pro-
file changes in differentiated LNCaP cells under the influence of hormone. The results indicated that 15 genes were 
down-regulated and 22 genes were up-regulated in T3-treated differentiated LNCaP cells in comparison to undif-
ferentiated state. Of all these genes, casein kinase 2 (CK2), a key component to enhance PI3K signaling pathway, was 
significantly increased upon T3 treatment only while the cells were differentiated. Further studies revealed that CK2 
inhibitors tetrabrominated cinnamic acid (TBCA) and 4, 5, 6, 7-tetrabromo-2H-benzotriazole (TBB) both reversed the 
T3-mediated repression of viral replication. Together these observations suggested a new approach to understanding 
the roles of T3 in the complicated regulation of HSV-1 replication during latency and reactivation.
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Background
The herpes viruses, herpes simplex 1 (HSV-1) and her-
pes simplex 2 (HSV-2) are infamous to the general 
public for causing unsightly and painful oral and geni-
tal lesions [1]. Curiously the third member of the alpha 
human herpes virus family (αHHV), human herpes virus 
3, or varicella zoster virus (VZV), commonly known as 
the chicken pox or shingles virus, is considered less of a 
taboo. This is perhaps due to the success and ubiquity of 
the VZV vaccine in the late 1980s and that lesions from 
VZV rarely present themselves more than a few times 
in a patient’s life, usually during early childhood and late 
adulthood [2]. Conversely, HSV-1 and HSV-2 symptoms 
occur sporadically throughout the patient’s lifetime with 
little predictability. It is this alternating duality between 
symptomatic, lytic, and asymptomatic, latent, periods 
that led to the name herpes or creeping from Latin. In 
addition to having lytic and latent periods, these herpes 
viruses have similar virion structures, protein function-
ality, genetic similarity, cause epithelial lesions and the 
affinity to reside almost exclusively in sensory ganglion 
during latency. Ironically the biological mechanisms that 
determine when and how these viruses exit latency and 
produce lytic symptoms is still undefined. Researchers 
believe that a complex relationship between the host’s 
immune system, nervous system, infected cell signal 
transduction, infected cell transcriptional regulation, and 
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Interestingly thyroid hormones, play roles within the 
immune system, nervous system, cell signal transduction, 
transcriptional regulation, etc. and T3 fluctuations are 
often linked to environmental stress [1]. These associa-
tions led to the hypothesis that thyroid hormones play a 
role in the suppression and reactivation of herpes viruses. 
To test this hypothesis our lab has studied the effect of 
thyroid hormone treatments on HSV-1 infections using 
different models. In addition, our lab has reported results 
from two retrospective clinical data analyses where 
patients with thyroid hormone complications increased 
the odds ratio of having herpes virus reactivation [3, 4]. 
The first study identified that several specific age/gender 
hospitalized patient groups at a comprehensive research 
medical center in urban Taiwan, with thyroid disorders 
were 2 times more likely to also have a αHHV [4]. The 
second study identified that hospitalized patients at a 
regional hospital in rural Maryland with thyroid disor-
ders were 3 times more likely to have VZV diagnoses [3]. 
To understand these clinical observations, our lab stud-
ies cellular thyroid hormone action in regards to tran-
scriptional regulation and signal transduction and have 
found that both mechanisms might be affecting HSV-1 
infections.
The nuclear activity of T3 and its receptor (TR) family 
has been studied for decades [5–22]. The most well char-
acterized mechanisms involve the transcriptional regula-
tion of genes that are transcriptionally repressed in the 
absence of T3 and activated upon ligand TR. Most these 
genes contain a T3 response element (TRE) within its 
promoter. The traditional TRE, known as a direct repeat 
4 (DR4) is characterized by containing two hexameric 
half-sites, with a 5′-AGGTCA-3′ consensus sequence, 
separated by any 4 nucleotides. Typically, the TR DNA 
binding domain (DBD) binds to the downstream half-
site with retinoic acid X receptor (RXR) occupying the 
upstream half-site, forming a heterodimer. TR homodi-
mers are also reported. In the absence of T3, the complex 
either bind loosely allowing repressive histones to block 
transcription or the complex can participate in recruiting 
repressive histone modifying enzymes. Upon T3 bind-
ing to the TR the complex undergoes a conformational 
change which recruits transcription activating histone 
modifying enzymes. Other, less common, TRE arrange-
ments such as single half-sites, inverted repeats (IR) and 
palindromes found on the TSHβ, lysozyme silencer, and 
TSHα genes (respectively) are not as well characterized. 
Epidermal growth factor receptor, myosin heavy chain β, 
prolactin, thyroid-stimulating hormone α, thyroid-stim-
ulating hormone β, thyrotropin-releasing hormone, type 
II 5′-deiodinase and the HSV-1 TK promoter and impart 
a regulatory pattern seemingly opposite of the traditional 
DR4 TREspositive regulation [22–26]. When T3 is absent 
genes with these negative TRE (nTRE) are transcription-
ally activated and upon T3 binding the transcription is 
repressed. These nTREs are found on the promoters of 
genes that well known to be repressed by T3 feedback 
inhibition.
T3 was also shown to influence PI3K signaling [27, 28]. 
In addition, the hormone exhibited non-genomic  func-
tions to control physiological functions. The actions were 
initiated by receptors at the plasma membrane or in the 
cytoplasm. The receptors mentioned in this category are 
either TR isoforms or integrin, for example, αvβ3 [29]. 
For example, TR is reported to interact with the Pi3K 
regulatory subunit Pi3KR1 resulting in increased Pi3K 
activity. Therefore, it appeared that T3/TR used many 
mechanisms to expand their regulatory roles in biol-
ogy. However, it is still unclear regarding its molecular 
mechanisms.
Differentiated human LNCaP cells have been devel-
oped as a proxy of neurons for investigating the regula-
tion of HSV-1 gene expression and replication [30–32]. 
This differentiated cell line is not a true sensory neuron 
of trigeminal ganglia or dorsal root ganglia where HSV-1 
usually infected during latency, but demonstrated impor-
tant human neuron-like morphology and physiology. 
The cells following differentiation exhibited long neurite-
like processes, rounding of the cell body, the presence of 
secretory granules as well as physiological markers such 
as the expression of chromogranin-A, differentiation-
specific ionic conductances, neuron-specific enolase 
(NSE), and the secretion of mitogenic neuropeptides 
neurotensin, and parathyroid hormone-related peptide 
[33–36].
Herpes virus transcriptional regulation by TR and T3
Several decades old and our recent studies have explored 
the nTRE in the promoter of the HSV-1 thymidine kinase 
(TK) gene [37–39]. Initially this promoter was believed 
to be insensitive to treatments in most cells but activated 
in pituitary cells upon T3 [39]. More recently it has been 
shown that T3 can cause the repression of TK transcrip-
tion in the certain neuron-like differentiated cell types 
that expresses the appropriate cofactors [32, 37]. These 
conditions mirror the only cellular environment where 
herpes virus latency exists, sensory neurons. In addition, 
our lab showed that T3 treatment of these infected differ-
entiated neuron-like cells had markedly reduced HSV-1 
replication compared to controls. The virus retained the 
ability to replicate normally after the T3 was removed 
from the system, mimicking latency and reactivation 
[32, 40]. Our observations however, puzzle our virologist 
colleagues since HSV-1 TK is not considered an essen-
tial gene to viral replication. Therefore, we continue to 
explore other mechanisms that support our findings. In 
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a parallel we have tested the ability of T3 to repress the 
VZV nucleotide kinase (VZV-PK) in transfection experi-
ments. Similarly, to transfection experiments with HSV-1 
TK, VZV-PK promoter activity is also repressed by T3 
treatment [3].
T3 signal transduction regulation
It has been realized that signaling pathway activated via 
PI3-kinase (PI3K) and Akt is necessary to repress HSV-1 
reactivation [41]. Studies indicated that PI3K activation 
by nerve growth factor (NGF) interaction with its high-
affinity tropomyosin receptor kinase (TrkA) generated a 
cascade of signals resulting in neuronal gene expression 
changes thus promoting latent infection. This observa-
tion was supported by a number of investigations show-
ing that addition of anti-NGF antibodies to the explanted 
trigeminal ganglia (TG), superior cervical ganglia (SCG), 
and eyes of latently infected animals causing more virus 
shedding and increased reactivation  [42]. Several down-
stream targets of PI3K/Akt pathway were discussed 
in terms of their functions in latency and reactivation. 
For instance, the mTORC1 kinase is one of the primary 
objects and it played a critical role in maintaining latency  
[43]. The mTORC1 was sufficient to regulate many pro-
teins including eIF4E-binding proteins (4E-BPs), which is 
a host cell translation repressor controlling cap-depend-
ent mRNA translation and temporary disruption was 
sufficient to reactivate the virus [43]. Factors/episodes 
participating in altering PI3K/Akt pathway may have a 
role in modulating HSV-1 latency and reactivation but 
the detailed mechanisms were unclear.
Previous reports showed that without affecting cell 
viability T3 was sufficient to control HSV-1 gene expres-
sion and replication in human neuron-like cells by target-
ing key viral genes [1, 30–32, 37]. It is not known if the 
hormone influenced the PI3K/Akt cascaded to produce 
the regulation. Our ongoing study attempts to investigate 
the gene expression profile changes upon T3 treatment 
comparing differentiated and undifferentiated condi-
tions. Several genes exhibited significant expression level 
changes, and function inhibition of one gene reversed 
T3-mediated repression and promoted viral replication.
HSV‑1 infected murine trigeminal ganglion (TG) explant
To correlate our clinical findings with our molecular biol-
ogy data and our hypothesis we performed a small animal 
experiment. Explanted TG from mice latently infected 
with HSV-1 treated with T3 exhibited delayed viral release 
compared to no treatment (Fig.  1A). Over the 8-day 
period post explant, samples from the two culture groups 
were analyzed by plaque assay for infectious viral parti-
cles (ivp). The untreated group began releasing measur-
able ivp at day 5 which increased over the remaining days 




































































Fig. 1 A HSV-1 infectious viral particles (ivp) released from T3 treated latently infected mouse TG explants. TGs from mice n = 10 latently infected 
with HSV-1 were explanted 30 days post infection. TG explants were separated into replicates of two treatment groups, +T3 and −T3, and were cul-
tured for 8 days post explant. Media from each replicate was quantitatively tested daily for HSV-1 ivp via plaque assay. Two-way ANOVA with Holm-
Sidak post hoc analysis suggests that statistically significant differences in ivp between +T3 and −T3 treatment at days 6, 7, and 8. Asterisk denotes 
p < 0.001. B PI3K Pathway is active in differentiated LNCaP cells with pAkt increase in differentiated cells. Western blot was performed using rabbit 
monoclonal IgG antibody against phospho-AKT pSer473 (ThermoSci, Cat#: OMA-03061) and mouse antibody AKT (Rockland, Cat#: 200-301-401) at 
a dilution of 1:1000 followed by the addition of conjugated secondary antibody for detection on extract from undifferentiated and differentiated 
LNCaP cells. C PI3K inhibitor reversed T3-mediated repression HSV-1 viral replication from differentiated LNCaP cells treated with 100 nM T3 and/
or 20 µM LY294002 (Sigma Aldrich, cat#: L9908) was measured quantitatively by FLICIT assays [68]. In short, Vero cells were seeded on 384-well 
plates followed by exposure to media from EGFP HSV-1 infected cultures. The infected media samples were applied in serial dilutions in replicates 
and were incubated for 8–18 h when EGFP was observed. The numbers of total cells and infected cells were imaged and quantified by the BioTek 
Cytation3 fluorescent imaging station and Gen5 software then used to calculate the viral titer using an inverse Poisson’s equation as previously 
described. Two-way ANOVA with Holm-Sidak post hoc analysis suggests that statistically significant differences in fluorescently labeled infected cells 
per mL exists. a p < 0.018, b p < 0.004, c p < 0.012, d p < 0.035
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measurable particles until the 8th day, which were four-
fold lower compared to the untreated explants (Fig. 1A).
PI3K/Akt pathway is active in differentiated LNCaP cells 
and contributed to T3‑mediated regulation of HSV‑1 
replication
Differentiated LNCaP cell is considered a human neuron-
like cells due to its physiological similarity to neurons. We 
have developed a protocol (T3 removal assays) to measure 
the effects of hormone on neurotropic virus replication 
such as HSV-1 [32, 40]. In short, two groups of cells were 
infected under T3 for 48 h then the hormone was removed 
from one group and the T3 regulatory effects were meas-
ured by either plaque assays or FLICIT assays at 96 hpi 
[44]. It was speculated that PI3K/Akt signaling is active 
in differentiated LNCaP since it was very suppressive to 
HSV-1 replication in comparison to undifferentiated con-
dition [32, 40]. This hypothesis was tested first by Western 
blot analyses using antibodies against total Akt and phos-
pho Akt (pAkt) on extracts from undifferentiated and dif-
ferentiated LNCaP cells. The results demonstrated that 
the level of pAkt was quite low if there was any in undif-
ferentiated cells but significantly increased when cells 
were differentiated (Fig. 1B). The PI3K suppressive effects 
on HSV-1 replication was studied by inhibitor LY294002, 
which was shown to reactivate HSV-1 from latency by 
blocking PI3K pathway [41, 43, 45]. The results showed 
that LY294002 reversed T3-mediated repression (Fig. 1C). 
These observations together indicated that differentia-
tion activated the PI3K/Akt signaling pathway of LNCaP 
cells and this activation participated in the T3-mediated 
repression of HSV-1 replication.
PI3K pathway related gene expression profiles 
of differentiated LNCaP under T3 treatment
To address the impact of T3 on the PI3K pathway in dif-
ferentiated cells compared to undifferentiated conditions, 
we performed quantitative PrimePCR® PI3K-Akt Array 
Assays to measure the expression profile of PI3K related 
genes. 84 genes were analyzed (complete data in Addi-
tional file 1: Figure S1). Of all these genes, the expression 
of 15 genes were decreased and 22 genes were increased 
significantly in T3-treated differentiated LNCaP cells 
when compared to undifferentiated LNCaP (Fig.  2A). 
For example, eIF4E and its regulator eIF4EBP1 showed 
opposite expression profile (Fig.  2A). To be specific, 
eIF4E from differentiated cells was identified to have sev-
enfold expression increase in comparison to undifferen-
tiated condition. eIF4EBP1, however, exhibited fivefold 
decrease. In addition, eIF2AK2, commonly known as 
PKR, reported to play a role in blocking HSV-1 transla-
tion, displayed a two-fold increase in T3-treated differen-
tiated cells (Fig. 2A). Together the analyses suggested that 
PI3K gene expression was hugely influenced by T3 and 
may have critical roles in controlling viral replication in 
differentiated condition.
Roles of casein kinase 2 in HSV‑1 replication in T3‑treated 
differentiated LNCaP cells
Casein kinase 2 (CK2) is a serine/threonine protein 
kinase that targets a number of proteins such as casein 
[46]. The kinase is composed of a tetramer of α, α’, and 
two β subunits [47, 48]. The PrimePCR assays showed 
that casein kinase 2 α1 (CSNK2A1) was significantly 
upregulated in T3-treated differentiated LNCaP cells 
(Fig. 2A). It was shown that CK2 can promote PI3K/Akt 
signaling by inhibiting PTEN, a suppressor of Akt/PKB 
signaling pathway [49–54]. To test the hypothesis that 
TH promoted HSV-1 replication suppression in differen-
tiated LNCaP by enhancing PI3K signaling via CK2, an 
inhibitor of CK2, TBB was first used in HSV-1 infection 
of differentiated LNCaP cells in the presence of T3. The 
results indicated that hormone was suppressive to the 
viral replication and removal of T3 at 96 hpi activated the 
viral replication repressed by T3, suggesting the experi-
ment was valid (Fig.  2B). The TBB treatment somehow 
overturned the T3-mediated suppression (Fig.  2B). It is 
likely due to the blocking of the CK2 activity.
Although TBB is widely used as a CK2 inhibitor, it was 
reported to have more effects on other kinase [55–58]. 
To confirm the roles of CK2 in this T3-mediated HSV-1 
replication regulation, a recently reported CK2 inhibitor, 
TBCA, was used since it exhibited more specific inhibition 
on CK2 [59, 60]. To distinguish the importance of differen-
tiation, undifferentiated cells were infected in the presence 
of T3 with or without TBCA and the results demonstrated 
that there was no difference in terms of the strength of 
viral replication (data not shown). However, when the cells 
were differentiated, T3 repressed the viral replication and 
hormone washout at 96 hpi recovered the viral replication 
previously blocked by T3 (Fig. 2C). The TBCA treatment, 
like the TBB, abolished the T3-mediated suppression 
(Fig. 2C). Together these results supported the hypothesis 
that increased expression of CK2 by T3 may have a role 
in modulating PI3k/Akt pathway in differentiated human 
neuron-like cells to suppress HSV-1 replication.
Conclusions
Using this model, we were able to address the impor-
tance of differentiation during HSV-1 latency since the 
HSV-1 infection of undifferentiated LNCaP was very effi-
cient and the differentiation significantly decreased the 
viral replication [31, 32, 40]. However, it is important to 
realize the limitations of this model. For example, it is a 
human neuroendocrine prostate cancer cell line and can 
only serve as an in  vitro model without reflecting the 
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real situations of latent infections. HSV-1 replication, 
although reduced dramatically, never established a bona 
fide latency in this model.
With these limitations in mind, this model has sev-
eral advantages for HSV-1 study. First, it can be easily 
induced to differentiate simply by androgen deprivation 
[61] with consistent results and the differentiation is 
usually achieved within 2 weeks and the cells can sur-
vive in this condition for up to a month with normal 
culture condition without the addition of NGF. In addi-
tion, these infected cells when treated with T3 exhibit 
a marked reduction in HSV-1 replication and release. 
While not considered a gene essential to replication in 
lytic infections, HSV-1 TK transcription is substantially 
reduced upon T3 treatment [62]. TK has been referenced 
as one of the necessary genes for efficient reactivation in 
neurons since other genes are also expressed at the very 
beginning of the reactivation [63, 64]. This leads us to 
consider the transcriptional regulation of TK by T3, one 
of several factors in the control and switch between her-
pes latency and reactivation. We further hypothesize that 
other additional T3 mechanisms, such as PI3K signaling, 
also play a role in this complex switch.
While cytoplasmic TR acting with PI3K has been 
reported we have not yet explored this mechanism exper-
imentally in our system. We plan to further investigate 
Fig. 2 A Transcription profiles of genes involved in PI3K/Akt pathway measured by qRT-PCR arrays. Undifferentiated and 5-day differentiated LNCaP 
cells plated on poly-d-lysine coated T75 flasks were treated with and without 100 nM T3 for 48 h. The total RNA was purified by TRIZOL and the 
cDNA was synthesized using RT2 first strand kit (QIAGEN, cat#: 330401). For the transcriptome heatmaps assessment, the cDNA was subjected to 
qRT-PCR array analyses via PI3K-AKT signaling pathway (SAB Target List) H96 (BIO-RAD, cat#: 100-34223). The protocol was described essentially by 
the manufactures based on the CFX Connect™ Real-Time PCR Detection System (BIO-RAD Cat# 1855200). Amplification was plotted and analyzed 
in triplicates using the BIO-RAD CFX manager software provided by the manufacturer. For each gene, the brightest red squares indicate at least a 
fourfold increase over the brightest blue square. A Showed the select genes from PI3K-AKT target list modulated significantly by T3 treatment and 
differentiation. Akt, EIF, and mTOR genes regulated by T3 and differentiation. B CK2 inhibitor TBB disrupts T3 mediated reduction of viral replication. 
The viral replication was measured by T3 removal assays [32] and FLICIT assays as shown in B with modification. TBB (Santa Cruz Bio, cat#: sc-202830) 
was added at 1 µM for CK2 inhibition. In short, differentiated cells were infected with HSV-1. At 48 hpi, infected cells were treated with (1) T3, (2) T3 
washout, (3) T3 plus TBB, or (4) T3 washout plus TBB. The culture media were collected at 96 hpi and subjected to PLICIT assays. The results showed 
that infection with 100 nM of T3 reduced viral replication and hormone washout reversed this reduction. The addition of TBB disrupted the T3–
mediated repression. FLICIT was reported previously [68] and described in the figure. Data in triplicates, two-way ANOVA with Holm-Sidak post hoc 
analysis suggests that statistically significant differences in fluorescently labeled infected cells exists; a, b, c, d, e p < 0.001. C TBCA reversed T3-medi-
ated suppression of viral replication in differentiated cells. LNCaP cells were infected under treatment of no T3, with T3, 110 nM TBCA (Millipore, cat#: 
218710), or T3 + TBCA followed by plaque assays to measure the release of infectious viruses. No suppression of viral replication was observed for 
undifferentiated cells under the influence of T3 and/or TBCA when analyzed by ANOVA (data not shown). T3 removal assays as described in A were 
used to investigate the effects of TBCA. At 48 hpi, infected cells were treated with (1) T3, (2) T3 washout, (3) T3 plus TBCA, or (4) T3 washout plus TBCA. 
It is shown that TBCA, similar to TBB, reversed the suppression of viral replication by T3 as measured by viral plaque assay. Data in triplicates were 
analyzed by Two-way ANOVA with Holm-Sidak post hoc analysis suggests that statistically significant differences in pfu per mL exists; a p < 0.001, b 
p < 0.046, c p < 0.040
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the roles of both genomic and nongenomic TR action 
using siRNA against key Pi3K, CK2, and TR subunits and 
isoforms. Currently our data supports that T3/TR viral 
suppression is due to genomic suppression of the viral 
genome and genomic regulation of CK2 and Pi3K path-
way components which leads to additional nongenomic 
regulation. Furthermore, we have identified putative 
TREs on the promoter region of CK2 and plan to confirm 
them with a series of mutation experiments and electro-
mobility shift assays.
The relationship between T3 and CK2 was not exten-
sively investigated. Most studies showed that CK2 phos-
phorylated TR isoforms or corepressor [20, 65, 66]. 
Thyroid hormone was reported to enhance casein kinase 
activity in the liver of rat [67]. In our study, HSV-1 repli-
cation was retarded and inhibitors against CK2 was suf-
ficient to rescue the virus’s ability to replicate at normal 
levels. Based on our clinical, in vivo, in vitro, and molec-
ular biology observations, it is likely that both genomic 
and non-genomic effects of T3 play a role in the suppres-
sion of herpesvirus infection and potentially participate 
in the complex regulation of latency and reactivation.
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